Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ·Healthcare·Biotechnology
$2.21
+1.15%
Mkt Cap $163.55M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+217.5%
Consensus $7.00 vs current $2.21
NASDAQ·Healthcare·Biotechnology
$2.21
+1.15%
Mkt Cap $163.55M
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
+217.5%
Consensus $7.00 vs current $2.21